Page last updated: 2024-09-02

exp3174 and enalapril

exp3174 has been researched along with enalapril in 1 studies

Compound Research Comparison

Studies
(exp3174)
Trials
(exp3174)
Recent Studies (post-2010)
(exp3174)
Studies
(enalapril)
Trials
(enalapril)
Recent Studies (post-2010) (enalapril)
23629436,3111,924859

Protein Interaction Comparison

ProteinTaxonomyexp3174 (IC50)enalapril (IC50)
Angiotensin-converting enzyme Homo sapiens (human)0.3536
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)2.7083
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)1.2
Angiotensin-converting enzymeRattus norvegicus (Norway rat)0.14
Angiotensin-converting enzyme 2 Homo sapiens (human)0.14

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hanada, K; Ikeda, T; Ikemoto, F; Kawai, N; Nakao, M; Nishikibe, M; Ohta, H; Suzuki, J1

Other Studies

1 other study(ies) available for exp3174 and enalapril

ArticleYear
Acute effects of E-3174, a human active metabolite of losartan, on the cardiovascular system in tachycardia-induced canine heart failure.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2001, Volume: 24, Issue:1

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiovascular System; Dogs; Echocardiography; Electric Stimulation; Enalapril; Heart Failure; Hemodynamics; Hormones; Imidazoles; Losartan; Male; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; Tachycardia; Tetrazoles; Ventricular Function

2001